<--- Back to Details
First PageDocument Content
Medicine / Clinical medicine / Anatomy / Kidney diseases / Organ failure / Membrane technology / Apolipoproteins / Nephrology / Chronic kidney disease / Hemodialysis / Dialysis / Lipoprotein
Date: 2013-09-12 07:15:30
Medicine
Clinical medicine
Anatomy
Kidney diseases
Organ failure
Membrane technology
Apolipoproteins
Nephrology
Chronic kidney disease
Hemodialysis
Dialysis
Lipoprotein

Studies in Patients with Kidney Diseases Principal Investigator: Florian Kronenberg Background: Patients with chronic kidney disease have one of the highest risks known for atherosclerotic complications. They have furthe

Add to Reading List

Source URL: www3.i-med.ac.at

Download Document from Source Website

File Size: 544,77 KB

Share Document on Facebook

Similar Documents

Insights into hypertension in children and adolescents in (South) Africa: the role of salt sensitivity Brian Rayner, Division of Nephrology and Hypertension, University of Cape Town

Insights into hypertension in children and adolescents in (South) Africa: the role of salt sensitivity Brian Rayner, Division of Nephrology and Hypertension, University of Cape Town

DocID: 1vj68 - View Document

Visterra to Present New Preclinical Results on VIS649, its Antibody for the Treatment of IgA Nephropathy, at the American Society of Nephrology Kidney Week Conference - VIS649 Reduced Serum IgA, with Favorable Safety Pro

Visterra to Present New Preclinical Results on VIS649, its Antibody for the Treatment of IgA Nephropathy, at the American Society of Nephrology Kidney Week Conference - VIS649 Reduced Serum IgA, with Favorable Safety Pro

DocID: 1uEgV - View Document

conferenceseries.com 9th International Conference on Nephrology: Kidney & Therapeutics  September 29-30, 2016 Orlando, USA

conferenceseries.com 9th International Conference on Nephrology: Kidney & Therapeutics September 29-30, 2016 Orlando, USA

DocID: 1uvE8 - View Document

Visterra to Present New Preclinical Results on VIS649, its Antibody for the Treatment of IgA Nephropathy, at the American Society of Nephrology Kidney Week Conference - VIS649 Reduced Serum IgA, with Favorable Safety Pro

Visterra to Present New Preclinical Results on VIS649, its Antibody for the Treatment of IgA Nephropathy, at the American Society of Nephrology Kidney Week Conference - VIS649 Reduced Serum IgA, with Favorable Safety Pro

DocID: 1uvxq - View Document

NRMP SMS Nephrology Match for Appointment Year 2016–2017: ASN Brief Analysis Kurtis Pivert, ASN Content and Media Analyst On December 2, 2015, the National Resident Matching Program (NRMP) released preliminary results

NRMP SMS Nephrology Match for Appointment Year 2016–2017: ASN Brief Analysis Kurtis Pivert, ASN Content and Media Analyst On December 2, 2015, the National Resident Matching Program (NRMP) released preliminary results

DocID: 1tmLJ - View Document